Abstracts

Search by keyword or author name.

Showing 852 abstracts.

Francesca Aweeka, Pharm.D., Alice M. Stek, M.D., Brookie M. Best, Pharm.D., ChengCheng Hu, Ph.D., Diane Holland, M.Phil., Ashwaq E. Hermes, Pharm.D., Sandra K. Burchett, M.D., M.S., Jennifer S. Read, M.D., M.P.H., M.S., DTM&H, Mark Mirochnick, M.D., Edmund Capparelli, Pharm.D. Lopinavir protein binding during pregnancy. Presented at: 14th Conference on Retroviruses and Opportunistic Infections.

Conference

14th Conference on Retroviruses and Opportunistic Infections

Study

P1026S

Study

P1041
Jennifer S. Read, M.D., M.P.H., M.S., DTM&H, Sandra K. Burchett, M.D., M.S., David E. Shapiro, Ph.D., Henry Pollack, M.D., James McNamara, M.D., Shiara Melissa Ortiz-Pujols, B.A., Ruth E. Tuomala, M.D. Low birth weight and preterm birth among infants of HIV-infected mothers according to maternal receipt of antiretroviral drug(s) during pregnancy: PACTG 367. Presented at: 41st Infectious Diseases Society of America Annual Meeting.

Conference

41st Infectious Diseases Society of America Annual Meeting
Low Darunavir (DRV) and Etravirine (ETR) Exposure When Used in Combination in HIV-Infected Children and Adolescents.

Study

P1058A
M Van Schalkwyk, A Bekker, E Decloedt, G Theron, M Cotton, B Best, E Capparelli, A Stek, J Norman, T Cressey, M Pinilla, M Mirochnick on behalf of the IMPAACT P1026s Protocol team. Low Isoniazid Concentrations in Pregnant and Postpartum Women treated for Tuberculosis Irrespective of Efavirenz-based ART co-treatment. Presented at: 20th International Workshop on Clinical Pharmacology of HIV, Hepatitis & Other Antiviral Drugs.

Conference

20th International Workshop on Clinical Pharmacology of HIV, Hepatitis & Other Antiviral Drugs

Study

P1026S
John ( Jack ) Moye, Jr., M.D., E. Richard Stiehm, M.D., James Bethel, Ph.D., Helene M.A. Paxton, M.S., M.T., Hildie Suter, B.S., Susan Plaeger, Ph.D., Howard Max Rosenblatt, M.D., Alan Landay, Ph.D., Lynne M. Mofenson, M.D., F.A.A.P., Bonnie J. Mathieson, Ph.D., Jonathan Kagan, Ph.D. Lymphocyte Activation and Memory In Perinatal HIV Transmission and Infant Infection.
William T. Shearer, M.D., Ph.D., Howard Max Rosenblatt, M.D., Stephen A. Spector, M.D., E. Richard Stiehm, M.D., Diane W. Wara, M.D., Steven D. Douglas, M.D., Katherine Luzuriaga, M.D., Elizabeth (Betsy) J. McFarland, M.D., Ram Yogev, M.D., Mobeen H. Rathore, M.D., Wende Levy, R.N., M.S., Bobbie L. Graham, B.S., Rebecca Oyomopito, M.S., Rebecca S. Gelman, Ph.D. Lymphocyte phenotyping in normal infants, children adolescents.
Tanya E. Reid, M.D. Lymphocyte Proliferation Studies in 5 Pediatric AIDS Patients Infected with Mycobacterium Avium-Intracellulare (MAI).
Edward M. Connor, M.D. Lymphocyte Subset Changes in Children With Advanced Symptomatic HIV Infection Treated With Oral Zidovudine.
Y Huo, K Patel, G Scott, G Siberry, Russell B Van Dyke, W Shearer. Lymphocyte subsets among HIV-exposed uninfected infants from birth to 12 months of age in IMPAACT P1025 study. Presented at: 7th International Workshop on HIV Pediatrics 2015.

Conference

7th International Workshop on HIV Pediatrics 2015